September 2026

Does Singulair Work Right Away? How Long It Takes to Start Working

By Your Health Magazine Health Information Team

Singulair can begin working after the first dose, but it does not provide immediate relief from a sudden asthma attack. In adult asthma trials, measurable benefits appeared after the first dose and continued through the 24-hour dosing interval. Whether you notice a difference that quickly depends on why you take it, the severity of your symptoms, and your individual response.

How Quickly Does Singulair Work?

Singulair is the brand name for montelukast, a prescription leukotriene receptor antagonist. It blocks leukotrienes, substances involved in airway inflammation, tightening of airway muscles, mucus production, and nasal allergy symptoms. Generic montelukast contains the same active ingredient and is available as regular tablets, chewable tablets, and oral granules.

According to the current montelukast prescribing information, treatment effects in placebo-controlled adult asthma trials were achieved after the first dose. However, that finding does not mean everyone will feel an obvious or dramatic improvement on the first day.

Reason for taking Singulair	What to expect
Long-term asthma control	Benefits can begin after the first dose, but improvement may be subtle and is assessed through symptom patterns, nighttime awakenings, lung function, and rescue-inhaler use.
Exercise-induced bronchoconstriction	The prescribing information uses a window of at least two hours before exercise. Protection varies, and some people may still develop symptoms.
Allergic rhinitis	Nasal symptoms may improve after treatment begins, but there is no single reliable timeline for when an individual will notice relief.

Why Singulair Is Not a Rescue Medicine

Although Singulair may start having a preventive effect relatively quickly, it is not a bronchodilator and does not rapidly open tightened airways. It should not be used in place of the rescue medicine prescribed for sudden wheezing, chest tightness, coughing, or shortness of breath.

If an asthma attack occurs, follow your personal asthma action plan and use the rescue treatment recommended by your healthcare professional. The MedlinePlus overview of asthma provides additional information about symptoms, attacks, and ongoing management.

Continue other asthma medicines as prescribed. Do not stop an inhaled corticosteroid, replace it with Singulair, or change any prescription treatment without guidance from the clinician managing your asthma.

How to Tell Whether It Is Helping

Because Singulair is mainly a controller medicine, its benefit may be easier to recognize by looking at several days of symptom patterns rather than waiting for a strong sensation immediately after a dose. Signs that asthma control may be improving include:

Less coughing or wheezing, especially at night
Fewer nighttime awakenings from breathing symptoms
Less limitation during usual activities
Less frequent need for a rescue inhaler
Fewer symptoms after exposure to known triggers

For allergic rhinitis, improvement may involve less sneezing, nasal itching, congestion, or runny nose. Keeping a brief symptom record can help you and your healthcare professional determine whether the medicine is providing a meaningful benefit.

Taking montelukast consistently as prescribed is important when evaluating its effect. For general information about scheduling the medicine, read about the timing of Singulair for different uses.

What If Singulair Does Not Seem to Be Working?

Do not take an extra dose because symptoms continue, and do not change when or how often you take the medicine without professional guidance. The MedlinePlus montelukast drug guide advises following the prescription directions carefully and not taking more than one dose within a 24-hour period.

Contact the prescribing clinician if symptoms remain uncontrolled, worsen, or require more rescue medicine than usual. A primary care clinician, allergist, pediatrician, or pulmonologist can review possible explanations, including:

Incorrect inhaler technique with other asthma medicines
Ongoing exposure to allergens, smoke, or other triggers
Missed doses or an inconsistent medication schedule
A respiratory infection or another condition affecting breathing
The need for a different controller treatment

For allergic rhinitis, montelukast is generally reserved for people who do not respond adequately to or cannot tolerate alternative allergy treatments. Its benefits should be weighed against its safety risks.

Important Mental Health Warning

Montelukast carries an FDA Boxed Warning concerning serious neuropsychiatric events. Reported symptoms include agitation, aggression, anxiety, depression, vivid dreams, sleep problems, confusion, hallucinations, suicidal thoughts, and other changes in mood or behavior. These events have been reported in people with and without a previous mental health condition.

Read the Medication Guide supplied with every refill, and promptly contact a healthcare professional if new behavior, mood, thinking, or sleep changes appear. Seek emergency help for suicidal thoughts, actions, or an immediate danger to yourself or someone else. The FDA’s montelukast safety communication explains the warning and why the medicine is not recommended as a first-choice treatment for mild allergic rhinitis.

When to Seek Care

Arrange a prompt appointment if asthma or allergy symptoms are not improving, interfere with sleep or daily activities, or require rescue treatment more often than usual. Seek emergency care for severe trouble breathing, difficulty speaking because of breathlessness, bluish or gray lips, confusion, fainting, or symptoms that do not respond to the prescribed rescue medicine.

In short, Singulair may start producing a measurable asthma-control effect after the first dose, but it does not work instantly like a rescue inhaler. The most useful measure is whether symptoms and rescue-medicine needs improve over time while the medication is taken consistently under medical supervision.